<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8d9/4048209/fd72d68df911/pone.0098641.g003.jpg"/> </div> <div class="text-side"> <h1>Insulin-like-growth-factor-binding-protein-3 (IGFBP-3) contrasts melanoma progression in vitro and in vivo.</h1> <p>Inverse correlation between immuno-histochemical expression of IGFBP-3 and MMP-9.Comparison of the immunohistochemistry for IGFBP-3 (A, C, E) and MMP-9 (B, D, F) in sequential sections obtained from primary melanomas and dermal metastases. The asterisks mark the melanocytes nests while the arrows indicate the stromal tissue. Original magnification X100. The IGFBP-3 and MMP-9 reactive cells were counted, and the scores determined, as described in Fig. 1 and in the Methods section.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/24905466/" target="_blank">24905466</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>